Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01792492 · ClinicalTrials.gov registry record
The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT01792492: Completed study, sponsored by Boston Medical Center.
NCT01792492 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01792492 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study will investigate the usefulness of an optical probe in the differentiation of thyroid cancer from normal thyroid tissue in a thyroidectomy specimen.
Primary Outcome
The objective is to assess a device called an optical probe for the differentiation of thyroid cancer from normal thyroid tissue, benign thyroid nodules or parathyroid glands, and the detection of thyroid cancer within lymph nodes using a hand-held spectroscope, compare the spectra from benign and malignant thyroid nodules and use this to discriminate benign from malignant nodules based on final histopathology or cytology as the gold standard.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-11 |
What the finished NCT01792492 record still lists
NCT01792492 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01792492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01792492 about?
NCT01792492 is a clinical study titled "The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study". This study will investigate the usefulness of an optical probe in the differentiation of thyroid cancer from normal thyroid tissue in a thyroidectomy specimen.
What is the current status of trial NCT01792492?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2009-06. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT01792492?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia